Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of iStent Inject and Inject W in the Management of Primary Open-angle Glaucoma
Sponsor: Centre Hospitalier Universitaire, Amiens
Summary
Primary open-angle glaucoma (POAG) is a chronic eye disease in which the only validated treatment is to lower intraocular pressure (IOP). It is the 2nd leading cause of blindness worldwide. The iStent® inject and inject W is an implantable device that is part of a new entity of so-called minimally invasive glaucoma surgery whose goal is to lower IOP with minimal tissue disruption in order to avoid the complications of conventional glaucoma surgery. This surgery is used in conjunction with cataract surgery in France. The primary objective is to study the 1-year efficacy and safety of combined cataract and iStent inject and inject W in the management of POAG in an observational, retrospective, controlled study of a cohort of POAG patients undergoing cataract surgery only.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
80
Start Date
2021-09-20
Completion Date
2022-09-20
Last Updated
2026-06-25
Healthy Volunteers
No
Interventions
cataract operation and istent
a cataract operation and the placement of one or two iStent inject or inject W at the same time
cataract operation only
Patients have a classic postoperative treatment after cataract.
Locations (1)
CHU Amiens Nord
Amiens, France